AI in Healthcare: 6 Uses That Are Actually Changing Patient Care

I have sat through more AI in healthcare demos than I can count. Most follow the same script: a polished dashboard, a slide claiming “99% accuracy,” and a confident promise that doctors will soon be freed from everything tedious. Then the pilot ends, the vendor moves on, and the nurses go back to the same workflow they had before, now with one more login to remember.

So when people ask me whether AI in healthcare is real or just another hype cycle, my honest answer is: both. On one hand, a lot of what vendors sell is noise. On the other hand, a smaller set of tools has quietly crossed the line from interesting to useful, and a few have the kind of evidence I would happily put in front of a skeptical chief medical officer. That second group is what this article is about.

I am not going to list every possible application. Instead, I want to walk through the uses of AI in healthcare that I believe are genuinely changing how clinicians care for patients today, what the research actually shows, and where I think health systems are still getting it wrong.

First, How Widely Are Clinicians Using AI in Healthcare?

A few years ago, the clinicians I worked with treated AI in healthcare like a curiosity. However, that has changed fast. The American Medical Association’s 2026 survey found that more than four in five physicians (81 percent) now use AI in their practices, more than double the 2023 rate of 38 percent. Specifically, the AMA polled 1,692 physicians across specialties, practice settings, and career stages between mid January and early February 2026.

What stands out to me is not just the headline number but the breadth. The average physician now uses AI for 2.3 different tasks, compared with 1.1 in 2023, and the most common uses are summarizing medical research and handling clinical documentation. In addition, confidence is growing: more than three quarters of physicians now believe AI improves their ability to care for patients, compared with 65 percent in 2023.

That is a remarkable shift for a profession that is, for very good reasons, slow to trust new tools. Still, adoption is not the same thing as impact. So let’s look at where the impact is showing up.

1. Ambient AI Scribes Are Giving Clinicians Their Attention Back

If you want to understand why ambient scribes became the breakout use of AI in healthcare, spend one evening with a primary care physician. The visits end at five. The charting, however, ends at nine. Doctors have a name for those late hours spent clicking through the electronic health record, and none of the names are polite.

An ambient scribe listens to the conversation between a clinician and a patient (with consent) and drafts the visit note. Then the clinician reviews, edits, and signs. That is it. In other words, there is no magic, just a very specific chore handled well.

What the Research Shows

The evidence here is stronger than I expected it to be this early. For example, a Yale led study in JAMA Network Open followed 263 physicians and advanced practice practitioners across six U.S. health systems who used an AI scribe for 30 days. Burnout prevalence fell from 51.9% to 38.8%, and clinicians reported better focus on patients and less documentation after hours. That last point is the one patients feel. After all, when a doctor is not typing, they are looking at you, and that shapes the whole patient experience.

Earlier work pointed the same way. Similarly, a Stanford Health Care pilot with 48 physicians over three months reported large, statistically significant drops in both task load and burnout, along with better usability scores.

Accuracy and Consent Still Matter

Now, the caveats, because I would be doing you a disservice without them. First, several authors of the Yale study disclosed ties to Abridge, the scribe vendor in that research. Second, a randomized trial comparing two scribe products found something more modest. Both scribes led to modest improvements in burnout and task load, and occasional inaccuracies in either tool meant physicians still had to stay vigilant.

That word, vigilant, matters. For instance, a scribe that invents a medication the patient never mentioned is not a time saver. Instead, it is a liability. In every rollout I have advised on, therefore, the rule is simple: the clinician owns the note. The AI drafts; the human signs.

There is also a consent issue that some organizations underestimated. A 2026 American Bar Association analysis flagged lawsuits in California and Illinois in which patients alleged that ambient scribes recorded them without adequate informed consent. Meanwhile, new state laws such as Texas TRAIGA, effective January 1, 2026, now require clinicians to tell patients when they use AI in clinical interactions. So if your clinic is using a scribe and nobody is telling patients plainly, fix that today.

2. A Second Set of Eyes in Breast Cancer Screening

Radiology is where AI in healthcare first found its footing, and mammography is where I think the most convincing patient outcome data now lives.

In many European programs, two radiologists read every mammogram. It works, but it is expensive and depends on a workforce already stretched thin. Sweden’s MASAI trial, therefore, asked a simple question: what happens if AI takes on part of that reading load?

The answer has been impressive. AI supported screening in the trial detected 29 percent more cancers than traditional screening, and the approach cut radiologists’ screen reading workload by 44 percent.

The part that convinced me, though, came later. Finding more cancers is only valuable if they are the ones that matter. The full results, published in The Lancet, showed AI supported mammography reduced breast cancer diagnoses in the years after a screening appointment by 12 percent, which is a key test of whether a screening program is working. These are interval cancers: the ones that show up between screenings, often more aggressive. Moreover, sensitivity was 6.7 percentage points higher in the AI supported group (80.5% versus 73.8%) at the same specificity, with consistent results across age and breast density.

One honest note: the benefit depends on the specific AI system and reading protocol, not on “AI mammography” as a general category. As a result, when a vendor cites MASAI to sell you a different product, ask them for their own data.

3. Sepsis Alerts That Clinicians Actually Act On

Sepsis is the clearest example I know of where speed saves lives. Unfortunately, it is also where early AI in healthcare tools disappointed many of us.

The problem was never a lack of alerts. Rather, it was too many bad ones. Many programs produce so many false alerts that providers learn to dismiss them without even looking. Worse, the Nature Medicine researchers pointed out that one of the most widely deployed sepsis warning systems caught only about one in three sepsis cases.

Johns Hopkins, by contrast, took a different path with a system called TREWS. Over two years, it monitored 590,736 patients across five hospitals and correctly flagged 6,877 sepsis cases before clinicians had started antibiotics. As a result, it helped doctors and nurses treat sepsis nearly two hours earlier on average and cut hospital mortality from the condition by about 18 percent.

The detail I find most instructive is the human one. Researchers saw the mortality reduction when a clinician confirmed the alert within three hours, compared with cases where alerts went unevaluated in that window. In other words, the AI did not save those patients on its own. It got the right information to the right person in time, and that person acted. Clinicians also appreciated that the system does not make sepsis decisions for them.

Precision helped adoption, too. For example, about 38 percent of TREWS alerts turned out to be true sepsis cases, far higher than older systems, and clinicians evaluated 89 percent of the alerts instead of dismissing them. That may not sound impressive at first. However, for anyone who has worked a hospital floor drowning in pop ups, it is the difference between an alert you trust and one you swat away.

4. Specialist Screening in an Ordinary Primary Care Office

This is the use case I bring up when people say AI in healthcare only helps big academic hospitals.

Diabetic retinopathy is preventable vision loss, and catching it early is straightforward if patients show up for screening. Many, however, do not. In fact, roughly half of patients with diabetes in the United States do not see an eye doctor every year, one of many barriers to accessible healthcare.

In April 2018, the FDA permitted marketing of the first device to use AI autonomously to detect a medical condition, a system from a company then called IDx that screens for diabetic retinopathy without requiring a specialist to review the results. Consequently, a primary care clinic could photograph a patient’s retinas during a routine diabetes visit and get an answer in minutes. In the study the FDA reviewed, the system correctly identified more than mild retinopathy 87.4 percent of the time and correctly ruled it out 89.5 percent of the time.

Think about what that does for a patient. Instead of a referral slip that sits in a purse for six months, the screening happens in the room they are already sitting in. That is a care gap closing, not just a technology milestone.

It also comes with clear boundaries. For instance, the FDA said clinicians should not use it for pregnant patients with diabetes, because retinopathy can progress very quickly during pregnancy. Good AI tools know what they are not for, and so should the people deploying them.

5. Imaging Triage: Where AI in Healthcare Is Most Regulated

Beyond mammography, imaging is where most regulated AI in healthcare tools live. The FDA authorized a record 331 AI devices in 2025, and as of its March 2026 update, the agency had authorized more than 1,400 AI devices since 1995. Most are in radiology, though they are spreading into cardiology and neurology. In practice, companies are using AI to speed up imaging, triage CT scans for serious conditions, and spot potential heart arrhythmias.

Triage, in particular, is the quiet win. For example, AI moves a head CT showing a possible bleed to the top of the worklist instead of leaving it to wait its turn behind routine scans. The radiologist still reads it. The patient just gets an answer sooner.

I do want to temper expectations around that big number, though. The FDA itself states plainly that its list is not a comprehensive resource of AI enabled medical devices. Furthermore, clearance is not proof of outcome benefit. A clearance letter tells you a product met a regulatory bar. However, it does not tell you it will work in your hospital, on your patients, with your scanners.

6. Keeping Up With the Medical Literature

This use of AI in healthcare gets less attention, but it is quietly one of the most common. In the 2026 AMA survey, 39 percent of physicians said they use AI to summarize medical research, up from 13 percent in 2024.

That makes sense. After all, no clinician can read everything published in their field. A good summarization tool can help a busy doctor check whether a guideline has changed before a patient visit. Where I get cautious, however, is when people use general purpose chatbots for this without any check on their sources. Summaries can be confidently wrong. Therefore, the safest habit I teach is to treat AI summaries as a map, then open the actual paper before changing care.

Where AI in Healthcare Still Falls Short

I would not trust an article on AI in healthcare that only covered the wins, so here are the problems I see most often in the field.

Training lags behind adoption. For example, a late 2025 Wolters Kluwer survey of physician assistants found 87 percent felt they needed more AI training, and only 32 percent said their workplace had clear guidelines for safe use. That gap is where mistakes happen.

Shadow AI is real. Experts have warned about staff using unapproved consumer AI tools in clinical settings. For instance, a nurse pasting patient details into a free chatbot to rewrite discharge instructions is a privacy incident waiting to happen, no matter how good the intentions. Likewise, using a free chatbot to translate those instructions is no substitute for qualified medical interpreter services.

Trust depends on safety and privacy. In the AMA survey, physicians rated data privacy (86%) and robust safety validation (88%) as critical to broader AI adoption.

Clinicians want a seat at the table. About 85 percent of physicians said they want a voice in AI adoption decisions or a direct role in them. In fact, every failed rollout I have seen had one thing in common: leadership introduced the tool to the people who would use it only after someone signed the contract.

Global guidance exists, but it needs enforcing. The World Health Organization has issued guidance on generative AI models in health, with over 40 recommendations for governments, technology companies, and providers. Among them is mandatory post release auditing and impact assessment by independent third parties when organizations deploy such models at large scale. I think that last idea deserves more attention, because a tool that worked at launch can drift as patient populations and workflows change.

What I Tell Health Leaders Before They Invest in AI in Healthcare

When an organization asks me where to start with AI in healthcare, I give the same short list:

• Start with a real problem, not a product. “Our doctors chart until nine” is a problem. By contrast, “we need generative AI” is not.
• Ask for outcome data in settings like yours. Not a demo. Not a slide. Instead, ask for peer reviewed or at least independently evaluated results.
• Define who owns the final decision. In every use case above, a human confirms, signs, or acts. Keep it that way.
• Tell patients plainly. Consent for ambient recording should be clear and easy to decline.
• Measure after go live. Track accuracy, alert response times, and clinician feedback for months, not weeks. Similarly, the same discipline applies to AI that flags readings in remote patient monitoring or wearable health devices.
• Train people before launch day. Otherwise, a tool nobody understands becomes a tool nobody uses, or worse, one people misuse.

What Patients Should Ask About AI in Healthcare

If you are a patient, you have every right to ask questions about AI in healthcare. A few worth raising:

• Does my care team use AI during my visit, and what does it do?
• Who reviews what the AI produces?
• Will anyone record my conversation, and can I say no?
• Where do you store my data, and who can access it?

A good clinic will answer without hesitation. If they cannot, that tells you something. Asking these questions is also part of strong patient engagement, and it builds the health literacy you need to make sense of the answers.

My Take on AI in Healthcare

AI in healthcare is not going to replace your doctor. Instead, what it is doing, in the best cases, is removing the friction that keeps your doctor from doing their job well: the late night notes, the reading backlog, the scan waiting in a queue, the subtle signs of sepsis buried in a chart.

The tools that work share a pattern. First, they do one specific job. Second, researchers have tested them where clinicians treat real patients. Finally, they hand the final call to a person. The tools that fail, by contrast, usually promise to do everything.

Overall, I am optimistic about AI in healthcare, but it is a working optimism. The technology is ready for more than most people think, and for less than most vendors claim. The gap between those two, in the end, is where careful leaders, informed clinicians, and engaged patients make the difference.

Frequently Asked Questions About AI in Healthcare

What is the most common use of AI in healthcare today?

Among physicians, documentation and research summarization lead the way. The AMA’s 2026 physician survey found these are the most frequently cited uses, with more than 80 percent of doctors now using AI professionally.

Do AI scribes really reduce doctor burnout?

Early evidence says yes, at least in the short term. For example, a multicenter study in JAMA Network Open found burnout fell from 51.9 percent to 38.8 percent after 30 days. However, a randomized trial of two scribe tools found more modest gains and stressed the need to check notes for errors.

Can AI detect cancer better than doctors?

AI works best alongside doctors, not instead of them. In the MASAI trial, AI supported screening with radiologists found more cancers and reduced interval cancers by 12 percent compared with standard double reading.

Who regulates AI in healthcare?

In the United States, AI tools that qualify as medical devices go through FDA review. The agency publishes its list of AI enabled medical devices, though it notes the list is not exhaustive. Globally, the World Health Organization has issued governance guidance for generative AI in health.

Is there evidence that AI saves lives?

There is promising evidence. For instance, researchers linked the TREWS sepsis system at Johns Hopkins to roughly an 18 percent drop in sepsis mortality when clinicians responded to alerts promptly.

Do patients have a right to know when clinicians use AI in their care?

Yes. Several states now require disclosure, and legal analyses have flagged lawsuits over ambient scribing without adequate consent. In any case, patients can always ask their provider directly.

References

1. American Medical Association. More Than 80% of Physicians Use AI Professionally: AMA Survey. 2026.
2. American Medical Association. AMA: AI Usage Among Doctors Doubles as Confidence in Technology Grows. 2026.
3. Radiology Business. AI Use Among American Doctors Has Doubled, New AMA Survey Says. 2026.
4. Olson KD, et al. Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout. JAMA Network Open, 2025. PubMed.
5. Newswise. Yale Study: AI Scribes Lower Physician Burnout, Lend Patients More Undivided Attention. 2025.
6. Shah SJ, et al. Ambient Artificial Intelligence Scribes: Physician Burnout and Perspectives on Usability and Documentation Burden. Journal of the American Medical Informatics Association, 2025. PubMed.
7. Lukac PJ, et al. A Randomized Clinical Trial of Two Ambient Artificial Intelligence Scribes. medRxiv, 2025.
8. ecancer. AI-Supported Mammography Screening Results in Fewer Aggressive and Advanced Breast Cancers. 2026.
9. Lund University. AI-Supported Breast Cancer Screening: New Results Suggest Even Higher Accuracy. 2025.
10. Scientific American. Algorithm That Detects Sepsis Cut Deaths by Nearly 20 Percent. 2022.
11. Freethink. A Sepsis-Catching AI Has Proven Effective in Hospitals.
12. HCPLive. FDA Approves Marketing for First AI Device for Diabetic Retinopathy Detection. 2018.
13. U.S. Food and Drug Administration. Artificial Intelligence-Enabled Medical Devices.
14. MedTech Dive. Tracking FDA-Authorized AI Medical Devices. 2026.
15. Physicians Practice. Physician AI Use Is Surging. Is Your Practice Ready? 2026.
16. World Health Organization. WHO Releases AI Ethics and Governance Guidance for Large Multi-Modal Models. 2024.
17. Orthopaedic Trauma Association. AI Corner: FDA Regulatory Landscape and AI Device Governance. 2026.